229 related articles for article (PubMed ID: 30754694)
1. 5-O-Acetyl-Renieramycin T from Blue Sponge Xestospongia sp. Induces Lung Cancer Stem Cell Apoptosis.
Chantarawong W; Chamni S; Suwanborirux K; Saito N; Chanvorachote P
Mar Drugs; 2019 Feb; 17(2):. PubMed ID: 30754694
[TBL] [Abstract][Full Text] [Related]
2. Chemistry of Renieramycins. 17. A New Generation of Renieramycins: Hydroquinone 5-O-Monoester Analogues of Renieramycin M as Potential Cytotoxic Agents against Non-Small-Cell Lung Cancer Cells.
Chamni S; Sirimangkalakitti N; Chanvorachote P; Saito N; Suwanborirux K
J Nat Prod; 2017 May; 80(5):1541-1547. PubMed ID: 28459574
[TBL] [Abstract][Full Text] [Related]
3. Renieramycin M Attenuates Cancer Stem Cell-like Phenotypes in H460 Lung Cancer Cells.
Sirimangkalakitti N; Chamni S; Suwanborirux K; Chanvorachote P
Anticancer Res; 2017 Feb; 37(2):615-621. PubMed ID: 28179308
[TBL] [Abstract][Full Text] [Related]
4. Renieramycin T Induces Lung Cancer Cell Apoptosis by Targeting Mcl-1 Degradation: A New Insight in the Mechanism of Action.
Petsri K; Chamni S; Suwanborirux K; Saito N; Chanvorachote P
Mar Drugs; 2019 May; 17(5):. PubMed ID: 31117253
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis-inducing Effect of Hydroquinone 5-
Maiuthed A; Pinkhien T; Chamni S; Suwanborirux K; Saito N; Petpiroon N; Chanvorachote P
Anticancer Res; 2017 Nov; 37(11):6259-6267. PubMed ID: 29061809
[TBL] [Abstract][Full Text] [Related]
6. 5-
Suksamai D; Racha S; Sriratanasak N; Chaotham C; Aphicho K; Lin ACK; Chansriniyom C; Suwanborirux K; Chamni S; Chanvorachote P
Mar Drugs; 2022 Mar; 20(4):. PubMed ID: 35447911
[TBL] [Abstract][Full Text] [Related]
7. Jorunnamycin A Suppresses Stem-Like Phenotypes and Sensitizes Cisplatin-Induced Apoptosis in Cancer Stem-Like Cell-Enriched Spheroids of Human Lung Cancer Cells.
Sumkhemthong S; Chamni S; Ecoy GU; Taweecheep P; Suwanborirux K; Prompetchara E; Chanvorachote P; Chaotham C
Mar Drugs; 2021 May; 19(5):. PubMed ID: 34063628
[TBL] [Abstract][Full Text] [Related]
8. Semisynthesis of 5-O-ester derivatives of renieramycin T and their cytotoxicity against non-small-cell lung cancer cell lines.
Buaban K; Innets B; Petsri K; Sinsook S; Chanvorachote P; Chansriniyom C; Suwanborirux K; Yokoya M; Saito N; Chamni S
Sci Rep; 2023 Dec; 13(1):21485. PubMed ID: 38057385
[TBL] [Abstract][Full Text] [Related]
9. NEAT1 contributes to the CSC-like traits of A549/CDDP cells via activating Wnt signaling pathway.
Jiang P; Xu H; Xu C; Chen A; Chen L; Zhou M; Haq IU; Wu X; Mariyam Z; Feng Q
Chem Biol Interact; 2018 Dec; 296():154-161. PubMed ID: 30291867
[TBL] [Abstract][Full Text] [Related]
10. Bishydroquinone Renieramycin M Induces Apoptosis of Human Lung Cancer Cells Through a Mitochondria-dependent Pathway.
Pinkhien T; Maiuthed A; Chamni S; Suwanborirux K; Saito N; Chanvorachote P
Anticancer Res; 2016 Dec; 36(12):6327-6333. PubMed ID: 27919953
[TBL] [Abstract][Full Text] [Related]
11. Light-Mediated Transformation of Renieramycins and Semisynthesis of 4'-Pyridinecarbonyl-Substituted Renieramycin-Type Derivatives as Potential Cytotoxic Agents against Non-Small-Cell Lung Cancer Cells.
Sinsook S; Buaban K; Iksen I; Petsri K; Innets B; Chansriniyom C; Suwanborirux K; Yokoya M; Saito N; Pongrakhananon V; Chanvorachote P; Chamni S
Mar Drugs; 2023 Jul; 21(7):. PubMed ID: 37504931
[TBL] [Abstract][Full Text] [Related]
12. Lusianthridin targeting of lung cancer stem cells via Src-STAT3 suppression.
Bhummaphan N; Petpiroon N; Prakhongcheep O; Sritularak B; Chanvorachote P
Phytomedicine; 2019 Sep; 62():152932. PubMed ID: 31100681
[TBL] [Abstract][Full Text] [Related]
13. Ti
Petpiroon N; Bhummaphan N; Soonnarong R; Chantarawong W; Maluangnont T; Pongrakhananon V; Chanvorachote P
Mol Pharmacol; 2019 Apr; 95(4):418-432. PubMed ID: 30737252
[TBL] [Abstract][Full Text] [Related]
14. Replacement of a quinone by a 5-O-acetylhydroquinone abolishes the accidental necrosis inducing effect while preserving the apoptosis-inducing effect of renieramycin M on lung cancer cells.
Cheun-Arom T; Chanvorachote P; Sirimangkalakitti N; Chuanasa T; Saito N; Abe I; Suwanborirux K
J Nat Prod; 2013 Aug; 76(8):1468-74. PubMed ID: 23876104
[TBL] [Abstract][Full Text] [Related]
15. Simplified Synthesis of Renieramycin T Derivatives to Target Cancer Stem Cells via β-Catenin Proteasomal Degradation in Human Lung Cancer.
Ei ZZ; Racha S; Yokoya M; Hotta D; Zou H; Chanvorachote P
Mar Drugs; 2023 Nov; 21(12):. PubMed ID: 38132948
[TBL] [Abstract][Full Text] [Related]
16. Synergistic Cytotoxicity of Renieramycin M and Doxorubicin in MCF-7 Breast Cancer Cells.
Tun JO; Salvador-Reyes LA; Velarde MC; Saito N; Suwanborirux K; Concepcion GP
Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31527453
[TBL] [Abstract][Full Text] [Related]
17. Chemistry of Renieramycins. 15. Synthesis of 22-O-Ester Derivatives of Jorunnamycin A and Their Cytotoxicity against Non-Small-Cell Lung Cancer Cells.
Sirimangkalakitti N; Chamni S; Charupant K; Chanvorachote P; Mori N; Saito N; Suwanborirux K
J Nat Prod; 2016 Aug; 79(8):2089-93. PubMed ID: 27487087
[TBL] [Abstract][Full Text] [Related]
18. Target Identification of 22-(4-Pyridinecarbonyl) Jorunnamycin A, a Tetrahydroisoquinoline Derivative from the Sponge
Iksen I; Sinsook S; Wattanathamsan O; Buaban K; Chamni S; Pongrakhananon V
Molecules; 2022 Dec; 27(24):. PubMed ID: 36558080
[TBL] [Abstract][Full Text] [Related]
19. Chemistry of Renieramycins. Part 19: Semi-Syntheses of 22-
Chamni S; Sirimangkalakitti N; Chanvorachote P; Suwanborirux K; Saito N
Mar Drugs; 2020 Aug; 18(8):. PubMed ID: 32785022
[TBL] [Abstract][Full Text] [Related]
20. Effect of SIRT1 activators and inhibitors on CD44+/CD133+‑enriched non‑small cell lung cancer cells.
Eroglu Z; Erdem C; Oktem G; Bozok Cetintas V; Duzgun Z
Mol Med Rep; 2020 Jul; 22(1):575-581. PubMed ID: 32377734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
